Search Results - "Gurell, Daniel"

Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times by Bruckner, Howard W, Bassali, Fred, Dusowitz, Elisheva, Gurell, Daniel, Book, Abe, De Jager, Robert

“…Patients have difficult unmet needs when standard chemotherapy produces a median survival of less than 1 year or many patients will experience severe…”
Get full text

Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy by Hirschfeld, Ariel, Gurell, Daniel, Har-Noy, Michael

“…Abstract Background Immune Checkpoint Inhibitor (ICI) immunotherapy is most effective in immune effector cell infiltrated ‘hot’ tumor lesions, such as occurs…”
Get full text

Broad safety impact of high-dose ascorbic acid and induction chemotherapy for high-risk pancreatic cancer by Bruckner, Howard, Hirschfeld, Azriel, Gurell, Daniel, Lee, King

“…Abstract only e15711 Background: High dose ascorbic acid inhibits many tumors in vitro. It may reduce chemotherapy's adverse hematologic events and improve…”
Get full text

Cholangiocarcinoma, sequential chemotherapy, and prognostic tests by Bruckner, Howard W, De Jager, Robert, Knopf, Elisheva, Bassali, Fred, Book, Abe, Gurell, Daniel, Nghiem, Van, Schwartz, Myron, Hirschfeld, Azriel

“…Routine blood tests are prognostic tests for patients with cholangiocarcinoma. New drug regimens may produce a median overall survival of 2 years or more. This…”
Get full text

Sodium Ion/Hydrogen Ion Exchange Inhibition: A New Pharmacologic Approach to Myocardial Ischemia and Reperfusion Injury by Levitsky, Josh, Gurell, Daniel, Frishman, William H.

“…Over the past few years, it has been shown that the cardiac myocyte plasma membrane sodium ion/hydrogen ion exchanger (NHE) plays an important role in the…”
Get full text

Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine Cancer by Bruckner, Howard W, Gurell, Daniel, Hirschfeld, Azriel

“…Bevacizumab (bev), when added to a moderate dose combination of previously failed cytotoxins, as a third- and fourth-line therapy for refractory gastric,…”
Get full text

Abstract CT061: Novel safety of high dose ascorbic acid and induction chemotherapy for high risk pancreatic cancer by Bruckner, Howard W., Hirschfeld, Azriel, Gurell, Daniel, Lee, King

“…Abstract Background: High dose ascorbic acid has been reported to have in vitro anticancer activity. Low dose combination chemotherapy with GFLIP (gemcitabine,…”
Get full text

Moderate dose serial therapy for aged and resistant patients with cholangiocarcinomas by Bruckner, Howard, Hirschfeld, Azriel, De Jager, Robert L., Bassali, Fred, Gurell, Daniel, Nghiem, Van, Book, AJ, Distenfeld, Shoshana, Schwartz, Myron E.

“…Abstract only e16160 Background: Advanced (Adv) intrahepatic IH Cholangiocarcinoma BD trials found multi-drug, sequences (GFLIO) safely expand eligibility (El)…”
Get full text

Survival and prognostic tests in a real-world phase II experience with a safe, moderate-dose, sequential chemotherapy (CT) algorithm (ALGO) for metastatic pancreatic adenocarcinoma (PANC) by De Jager, Robert L., Bruckner, Howard, Bassali, Fred, Hirschfeld, Azriel, Gurell, Daniel, Nghiem, Van, Distenfeld, Shoshana, Weinberger, Noah, Book, AJ

“…Abstract only e16763 Background: Gemcitabine (G), 5-fluorouracil (F), leucovorin (L), irinotecan (I), and oxaliplatin (O), (GFLIO) is safe, employs moderate…”
Get full text

Role of US-guided fine-needle aspiration with on-site cytopathologic evaluation in management of nonpalpable breast lesions by Buchbinder, S S, Gurell, D S, Tarlow, M M, Salvatore, M, Suhrland, M J, Kader, K

“…The purpose of this study was to evaluate the accuracy of ultrasound (US)-guided fine-needle aspiration (FNA), with radiographic follow-up or surgical…”
Get more information

An open-label trial of SMK treatment of advanced metastatic cancer by Hoffman, Steve, Bruckner, Howard, Del Priore, Giuseppe, Gurell, Daniel, Mull, Ruslan, Stega, Damian, Goodwin, Gail, Demurjian, Mike, Malanowska-Stega, Jeanetta

“…Abstract only e22095 Background: SMK is a novel therapy that creates alteration in defenses to oxidative stress and increases free radical availability to the…”
Get full text

COPD? by Scheinfeld, Meir H, Maniatis, Theodore, Gurell, Daniel

Get more information

Superficial femoral artery occlusive disease severity correlates with MR cine phase-contrast flow measurements by Mohajer, Kiyarash, Zhang, Honglei, Gurell, Daniel, Ersoy, Hale, Ho, Bernard, Kent, K. Craig, Prince, Martin R.

“…Purpose To evaluate how cine phase‐contrast (PC) flow data correlate with the severity of peripheral vascular disease (PVD). Materials and Methods Flow…”
Get full text